Announcements Trials
Browse Landscape

Phase

Phase 2 52Phase 3 23Phase NA 16Phase 1 15Phase 1/2 14Phase 4 8Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 6Recruiting 3Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 21Breast 14Other hematologic neoplasm 13Genitourinary 11Lymphoid 10Gynecologic 9Head & Neck 8Dermatologic 6CNS 6Sarcoma 5Myeloid 5Plasma cell 4Tumor-Agnostic 3Other 2Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Fatigue 1Critical Illness 1Anemia 1

Interventions

Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Classical hematology × Clear all
NCT00381836 2015-12-04

Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancer

University of Aarhus

Phase 2/3 Terminated
140 enrolled
Classical hematologyGenitourinary

Anemia, Fatigue, Neoplasms, Prostatic Neoplasms, Critical Illness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡